The Daily Dose: August 16, 2022

#Be flexible: The pandemic has taught us to be resilient, says a veteran voice of the Indian pharmaceutical industry, who is also President-DRL.

#Covid claim boom: Insurance giant Life Insurance Corporation (LIC) paid ₹2,334 crore towards COVID-19 claims in the first quarter ended June 30 this fiscal. This was 614 per cent higher than the amount of ₹327 crore paid for COVID-19 claims in the corresponding quarter of the previous financial year.

This increase in Kovid-19 claims may pay off on the first quarter financial performance of the country’s largest life insurer. There could be some bunch of claims related to the previous quarters, which cannot be ruled out.

#Nasal Vaccine: Biotech International’s intranasal Covid-19 vaccine, BBV154, has been proven “safe, well-tolerated and immunogenic” in subjects in controlled clinical trials, it said in a statement. BBV154 is a recombinant replication-deficient adenovirus vector vaccine with a pre-fusion stabilized spike protein.

#Vaccination of children: The twin viral concerns of Covid-19 and monkeypox in children, especially those under the age of 12, are a concern for some parents – especially since countries such as Israel, the US and the UK have immunized against this age group. started. COVID-19.

# Weary caregivers: According to a study by doctors at AIIMS Patna, caregivers of people with cancer go through psychological distress, which is often overlooked, affecting their quality of life and patient care as well. Lead author Dr Rakesh said the study took longer than proposed in the protocol due to the Covid-19 pandemic, which led to fewer hospital visits for cancer treatment.

Down with #Pfizer chief covid: The top executive of Pfizer, a major manufacturer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms. Chairman and CEO Albert Bourla said Monday that he has begun treatment with Pfizer’s Paxlovid pill and is self-isolating as he recovers.

Delay in the return of #Covid: Apple Inc. set a September 5 deadline for corporate employees to be in office at least three days a week, marking its latest return effort after Covid-19 spikes delayed its plans several times.

# Pharma @ 75: The Tough and Upheaval of the Pharma Journey – Hear to understand how the industry charts its course through patents, a pandemic, and supply disruptions currently underway.

Published on

16 August 2022


Leave a Comment